TIGAN (Pfizer Laboratories Div Pfizer Inc)
Welcome to the PulseAid listing for the TIGAN drug offered from Pfizer Laboratories Div Pfizer Inc. This Antiemetic [EPC],Emesis Suppression [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Pfizer Laboratories Div Pfizer Inc |
NON-PROPRIETARY NAME: | trimethobenzamide hydrochloride |
SUBSTANCE NAME: | TRIMETHOBENZAMIDE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Antiemetic [EPC],Emesis Suppression [PE] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2001-12-13 |
END MARKETING DATE: | 0000-00-00 |
TIGAN HUMAN PRESCRIPTION DRUG Details:
Item Description | TIGAN from Pfizer Laboratories Div Pfizer Inc |
LABELER NAME: | Pfizer Laboratories Div Pfizer Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 300(mg/1) |
START MARKETING DATE: | 2001-12-13 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 61570-079_860abf51-8d26-4b94-9d6d-00364af77556 |
PRODUCT NDC: | 61570-079 |
APPLICATION NUMBER: | NDA017531 |
Other TRIMETHOBENZAMIDE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: